Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-059144
Filing Date
2025-03-20
Accepted
2025-03-20 16:17:25
Documents
1
Period of Report
2025-03-20

Document Format Files

Seq Description Document Type Size
1 6-K d845432d6k.htm 6-K 11411
  Complete submission text file 0001193125-25-059144.txt   12432
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 25756670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)